Descriptive study of the adaptations of the rheumatological consultation during the COVID-19 pandemic

  • Miguel Perandones Psychophysical Rehabilitation Institute (IREP), Autonomous City of Buenos Aires, Argentina
  • Dafne Capelusnik Tel Aviv Sourasky Medical Center, Tel Aviv, Israel
  • Alejandro Ezquer Psychophysical Rehabilitation Institute (IREP), Autonomous City of Buenos Aires, Argentina
  • Pamela Giorgis Psychophysical Rehabilitation Institute (IREP), Autonomous City of Buenos Aires, Argentina
  • Virginia Carrizo Abarza Psychophysical Rehabilitation Institute (IREP), Autonomous City of Buenos Aires, Argentina
  • Agustina Alfaro Psychophysical Rehabilitation Institute (IREP), Autonomous City of Buenos Aires, Argentina
  • María Gisela Crespo Rocha Psychophysical Rehabilitation Institute (IREP), Autonomous City of Buenos Aires, Argentina
  • Tatiana Barbich Psychophysical Rehabilitation Institute (IREP), Autonomous City of Buenos Aires, Argentina
  • Juan Sevillano Psychophysical Rehabilitation Institute (IREP), Autonomous City of Buenos Aires, Argentina
  • Emilce Schneeberger Psychophysical Rehabilitation Institute (IREP), Autonomous City of Buenos Aires, Argentina
  • Marcos Rosemffet Psychophysical Rehabilitation Institute (IREP), Autonomous City of Buenos Aires, Argentina
  • Gustavo Citera Psychophysical Rehabilitation Institute (IREP), Autonomous City of Buenos Aires, Argentina
Keywords: pandemic, COVID-19, virtual consultations, in-person consultations, rheumatological diseases

Abstract

Introduction: COVID-19 pandemic had a great impact on society in general. The imposed isolation modified interpersonal relationships, including medical consultations. Objectives: describe the rheumatologic consultations in the Rheumatology Service from Instituto de Rehabilitación Psicofísica (IREP) during the COVID-19 pandemic and compare them with those received the previous year. Materials and methods: observational study. Consultations during March-September 2020 were recorded. Sociodemographics, numbers, and reasons for consultations made per patient were collected. A multiple logistic regression analysis was performed to estimate variables associated with the in-person consultation. Results: 1,703 consultations were registered. 798 patients consulted at least 1 time, and the median number of consultations per patient was 3 (IQR 1-12). The main method of consultation was by email (57%); only 13% were in person. The main reason was requesting prescriptions (60%) followed by consultations for the disease (23%). We observed a reduction in the total number of consultations compared to the same period in 2019 of 57% (3,961 consultations) and an even greater reduction of 94% in the number of in-person consultations (224 consultations). In-person medical consultation during the pandemic was independently associated with male sex (OR: 2,4, 95%CI 1,6-3,6), consultation due to illness (OR: 5,8, 95%CI 4,1-8,3) and lack of social coverage (OR: 2,3. 95%CI 1,6-3,3). Conclusions: rheumatologic consultations, especially in-person, were substantially reduced during the pandemic.

Author Biographies

Miguel Perandones, Psychophysical Rehabilitation Institute (IREP), Autonomous City of Buenos Aires, Argentina
Psychophysical Rehabilitation Institute (IREP)
Dafne Capelusnik, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel
Psychophysical Rehabilitation Institute (IREP), Autonomous City of Buenos Aires, Argentina, Department of Rheumatology
Alejandro Ezquer, Psychophysical Rehabilitation Institute (IREP), Autonomous City of Buenos Aires, Argentina
Psychophysical Rehabilitation Institute (IREP)
Pamela Giorgis, Psychophysical Rehabilitation Institute (IREP), Autonomous City of Buenos Aires, Argentina
Psychophysical Rehabilitation Institute (IREP)
Virginia Carrizo Abarza, Psychophysical Rehabilitation Institute (IREP), Autonomous City of Buenos Aires, Argentina
Psychophysical Rehabilitation Institute (IREP)
Agustina Alfaro, Psychophysical Rehabilitation Institute (IREP), Autonomous City of Buenos Aires, Argentina
Psychophysical Rehabilitation Institute (IREP)
María Gisela Crespo Rocha, Psychophysical Rehabilitation Institute (IREP), Autonomous City of Buenos Aires, Argentina
Psychophysical Rehabilitation Institute (IREP)
Tatiana Barbich, Psychophysical Rehabilitation Institute (IREP), Autonomous City of Buenos Aires, Argentina
Psychophysical Rehabilitation Institute (IREP)
Juan Sevillano, Psychophysical Rehabilitation Institute (IREP), Autonomous City of Buenos Aires, Argentina
Psychophysical Rehabilitation Institute (IREP)
Emilce Schneeberger, Psychophysical Rehabilitation Institute (IREP), Autonomous City of Buenos Aires, Argentina
Psychophysical Rehabilitation Institute (IREP)
Marcos Rosemffet, Psychophysical Rehabilitation Institute (IREP), Autonomous City of Buenos Aires, Argentina
Psychophysical Rehabilitation Institute (IREP)
Gustavo Citera, Psychophysical Rehabilitation Institute (IREP), Autonomous City of Buenos Aires, Argentina
Psychophysical Rehabilitation Institute (IREP)

References

I. Kaye AD, Okeagu CN, Pham AD, Silva RA, Hurley JJ, et al. Economic impact of COVID-19 pandemic on healthcare facilities and systems: international perspectives. Best Pract Res Clin Anaesthesiol 2021;35(3):293-306.

II. Both LM, Zoratto G, Calegaro VC, Ramos-Lima LF, Negretto BL, et al. COVID-19 pandemic and social distancing: economic, psychological, family, and technological effects. Trends Psychiatry Psychother 2021;43(2):85-91.

III. Kretchy IA, Asiedu-Danso M, Kretchy JP. Medication management and adherence during the COVID-19 pandemic: perspectives and experiences from low-and middle-income countries. Res Social Adm Pharm 2021;17(1):2023-2026.

IV. Di Fusco M, Shea KM, Lin J, Nguyen JL, Angulo FJ, et al. Health outcomes and economic burden of hospitalized COVID-19 patients in the United States. J Med Econ 2021;24(1):308-317.

V. Varona L, Gonzales JR. Dynamics of the impact of COVID-19 on the economic activity of Peru. PLoS One 2021 8;16(1):e0244920

VI. Ministerio de Salud de la Nación Argentina. Disponible en: https://www.argentina.gob.ar/noticias/salud-confirma-el-primer-caso-de-coronavirus-en-el-pais. Consultado: 11/4/2020.

VII. Boletín Oficial. Disponible en: www.boletinoficial.gob.ar/detalleAviso/primera/227042/20200320. Consultado: 11/4/2020.

VIII. World Health Organization. Disponible en: www.covid19.who.int. Consultado: 15/4/2020.

IX. BBC News. Disponible en: www.bbc.com/mundo/noticias-internacional-53892496. Consultado: 28/8/2020.

X. Johns Hopkins Coronavirus Resource Center. Disponible en: www.coronavirus.jhu.edu. Consultado: 5/9/2020.

XI. Ministerio de Salud de la Nación Argentina. Disponible en: www.argentinagob.gob.ar/salud/coronavirus-covid-19/sala-situacion. Consultado: 10/9/2020.

XII. Monti S, Balduzzi S, Delvino P, Bellis E, Quadrelli VS, et al. Clinical course of COVID-19 in a series of patients with chronic arthritis treated with immunosuppressive targeted therapies. Ann Rheum Dis 2020;79(5):667-8.

XIII. Calabrese C. COVID-19 and your rheumatology patients. Cleve Clin J Med 2020;10.3949/ccjm.87a.ccc027.

XIV. Santos CS, Morales CM, Álvarez ED, Castro CÁ, Robles AL, Sandoval TP. Determinants of COVID-19 disease severity in patients with underlying rheumatic disease. Clin Rheumatol 2020;39(9):2789-96.

XV. Isnardi CA, Gómez G, Quintana R, Roberts K, Berbotto G, Báez RM, et al. Características epidemiológicas y desenlaces de la infección por SARS-CoV-2 en pacientes con patologías reumáticas: primer reporte del registro argentino SAR-COVID. Rev Arg Reumatol 2021;32(1):7-15.

XVI. Richez C, Flipo RM, Berenbaum F, et al. Managing patients with rheumatic diseases during the COVID-19 pandemic: The French Society of Rheumatology answers to most frequently asked questions up to May 2020. Joint Bone Spine 2020;S1297-319X(20)30092-0.

XVII. Fragoulis GE, Evangelatos G, Arida A, et al. Treatment adherence of patients with systemic rheumatic diseases in COVID-19 pandemic. Ann Rheum Dis 2020;80(4):e60.

XVIII. Phadke NA, Del Carmen MG, Goldstein SA, et al. Trends in ambulatory electronic consultations during the COVID-19 pandemic. J Gen Intern Med 2020;1-3.

XIX. Nune A, Iyengar K, Ahmed A, Sapkota H. Challenges in delivering rheumatology care during COVID-19 pandemic. Clin Rheumatol 2020;39(9):2817-2821.

XX. Masini F, Gjeloshi K, Ferrara R, Pinotti E, Cuomo G. Rheumatic disease management in the Campania region of Italy during the COVID-19 pandemic. Rheumatol Int 2020;40(9):1537-1538.

XXI. Guaracha-Basáñez GA, Contreras-Yáñez I, Hernández-Molina G, González-Marín A, Pacheco-Santiago LD, et al. Clinical and bioethical implications of health care interruption during the COVID-19 pandemic: a cross-sectional study in outpatients with rheumatic diseases. PLoS One 2021 Jul 9;16(7):e0253718.

XXII. Adnine A, Soussan I, Nadiri K, Coulibaly S, Berrada K, et al. Patients with rheumatic diseases overlooked during COVID-19 pandemic: how are they doing and behaving? Curr Rheumatol Rev 2021 Aug 30;17(3):318-326.

XXIII. Opinc A, Brzezińska O, Makowska J. The impact of COVID-19 and healthcare system changes on the well-being of rheumatic patients. Reumatol 2021;59(2):73-84.

XXIV. George MD, Baker JF, Banerjee S, Busch H, Curtis D, et al. Social distancing, health care disruptions, telemedicine use, and treatment interruption during the COVID-19 pandemic in patients with or without autoimmune rheumatic disease. ACR Open Rheumatol 2021 Jun;3(6):381-389.

XXV. Hassen LM, Almaghlouth IA, Hassen IM, Daghestani MH, Almohisen AA, et al. Impact of COVID-19 outbreak on rheumatic patients' perceptions and behaviors: A cross-sectional study. Int J Rheum Dis 2020 Nov;23(11):1541-1549.

XXVI. Naddei R, Alfani R, Bove M, Discepolo V, Mozzillo F, et al. Increased relapse rate during COVID-19 lockdown in an Italian cohort of children with juvenile idiopathic arthritis. Arthritis Care Res (Hoboken) 2021;75(2):326-331.

XXVII. Avouac J, Molto A, Frantz C, Wanono S, Descamps E, Fogel O, et al. Evaluation of patients with rheumatoid arthritis in teleconsultation during the first wave of the COVID-19 pandemic. J Rheumatol 2022;49(11):1269-1275.

XXVIII. Di Iorio M, Cook CE, Vanni KMM, Patel NJ, D'Silva KM et al. DMARD disruption, disease flare, and prolonged symptom duration after acute COVID-19 among participants with rheumatic disease: A prospective study. Semin Artrhritis Rheum 2022;55:152025.

Published
2023-12-30
How to Cite
1.
Perandones M, Capelusnik D, Ezquer A, Giorgis P, Carrizo Abarza V, Alfaro A, Crespo Rocha MG, Barbich T, Sevillano J, Schneeberger E, Rosemffet M, Citera G. Descriptive study of the adaptations of the rheumatological consultation during the COVID-19 pandemic. Rev. Argent. Reumatol. [Internet]. 2023Dec.30 [cited 2024May15];34(4):123 -10. Available from: https://ojs.reumatologia.org.ar/index.php/revistaSAR/article/view/788
Section
Original Article